五行打油诗 发表于 2025-3-23 12:38:12

http://reply.papertrans.cn/15/1478/147797/147797_11.png

interrupt 发表于 2025-3-23 17:12:36

http://reply.papertrans.cn/15/1478/147797/147797_12.png

光亮 发表于 2025-3-23 21:43:44

http://reply.papertrans.cn/15/1478/147797/147797_13.png

洁净 发表于 2025-3-23 23:17:26

http://reply.papertrans.cn/15/1478/147797/147797_14.png

摆动 发表于 2025-3-24 03:11:16

Pyruvate Dehydrogenase Deficiency Disorders most commonly with penicillins and NSAIDs. The pathogenic mechanism of urticarial reactions can be divided into immunological (Type I, IgE-mediated or Type III complement activation) and non-immunological (degranulation of mast cells).

nocturia 发表于 2025-3-24 08:59:15

Gerard B. Odell,Henry S. Schuttaintaining QoL. This chapter addresses dAEs induced by cytotoxic and targeted therapies, radiotherapy, stem cell transplantation, immunotherapies, and CAR-T cell therapy. Proposed underling mechanisms and recommended treatment approaches for these dAEs are presented.

构成 发表于 2025-3-24 11:11:50

Gerard B. Odell,Henry S. Schuttance of offending drug classes is different than in adults—anti-infectives make the majority, followed by antipyretics and antiepileptics. In this chapter, unique CADR features in the pediatric population are discussed, and a morphologic approach, based on simple and complex/severe eruptions, is suggested.

WAG 发表于 2025-3-24 18:35:03

http://reply.papertrans.cn/15/1478/147797/147797_18.png

钢笔尖 发表于 2025-3-24 20:53:05

F. Sharp MD,D.-Z. Liu,X. Zhan,B. P. Ander a drug since the severity of skin manifestation does not necessarily mirror the severity of the systemic involvement. This chapter aims to provide a practical approach to a patient with a suspected drug eruption.

Albumin 发表于 2025-3-25 00:36:55

http://reply.papertrans.cn/15/1478/147797/147797_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions; Current and Future T Neil H. Shear,Roni P. Dodiuk-Gad Book 2019 S